CompletedNot Applicable

Long Term Follow up of Water Vapor Thermal Therapy (Rezum) for Benign Prostatic Hyperplasia (BPH)

Egypt86 participantsStarted 2021-03-01

Plain-language summary

This study aims to assess the effectiveness and morbidity of water vapor thermal therapy (Rezūm therapy) for benign prostatic hyperplasia (BPH). Data will be collected and analyzed from patients treated by Rezūm and followed up for 4 years prior to evaluating clinical outcomes.

Who can participate

Age range40 Years – 80 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients underwent rezum procedure for benign prostatic hyperplasia from 2 to 4 years Exclusion Criteria: * previous prostatic intervention * concurrent urological morbidity like urethral stricture * neurological disease like parkinson's disease

What they're measuring

change in prostate volume

Timeframe: 4 years

hange in International Prostate Symptom Score (IPSS)

Timeframe: 4 years

international index of erectile function (IIEF)

Timeframe: 4 years

Change in Post-Void Residual Urine

Timeframe: 4 years

Trial details

NCT IDNCT05982444

SponsorHelwan University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-01

View on ClinicalTrials.gov More Benign Prostatic Hyperplasia trials